Editorial
Glucagon-like peptide-1 receptor agonists and aspiration risk
BMJ · 22.10.2024 · q1986
DOI: 10.1136/bmj.q1986 ↗Kurz gefasst
Editorial in der Zeitschrift BMJ, online erschienen am 22.10.2024. Verfasst von Daniel I McIsaac und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology and Pain Medicine, University of Ottawa, Ottawa, ON, Canada dmcisaac@toh.ca. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 13 Literaturangaben.
Abstract (Originalsprache)
Balancing the harms and risks of periprocedural management
Autor:innen und Institutionen
- Department of Anesthesiology and Pain Medicine, University of Ottawa, Ottawa, ON, Canada dmcisaac@toh.ca.
- Department of Anesthesiology and Pain Medicine, University of Ottawa, Ottawa, ON, Canada.
Zitieren
APA
McIsaac, D. I., & Bryson, G. L. (2024). Glucagon-like peptide-1 receptor agonists and aspiration risk. BMJ, q1986. https://doi.org/10.1136/bmj.q1986
Vancouver
McIsaac DI, Bryson GL. Glucagon-like peptide-1 receptor agonists and aspiration risk. BMJ. 2024:q1986. doi:10.1136/bmj.q1986
BibTeX
@article{McIsaac2024,
author = {McIsaac, Daniel I and Bryson, Gregory L},
title = {Glucagon-like peptide-1 receptor agonists and aspiration risk},
journal = {BMJ},
year = {2024},
pages = {q1986},
doi = {10.1136/bmj.q1986}
}
EUVIMED